Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Atropine
Drug ID BADD_D00189
Description An alkaloid, originally from Atropa belladonna, but found in other plants, mainly solanaceae.
Indications and Usage For the treatment of poisoning by susceptible organophosphorous nerve agents having anti-cholinesterase activity (cholinesterase inhibitors) as well as organophosphorous or carbamate insecticides.
Marketing Status Prescription; Discontinued
ATC Code A03BA01; S01FA01
DrugBank ID DB00572
KEGG ID D00113
MeSH ID D001285
PubChem ID 174174
TTD Drug ID D0RG3O
NDC Product Code 69205-034; 60592-049; 11704-105; 63827-1015; 13371-488; 12714-034; 11704-106; 64181-0048; 11704-107; 11704-101; 11704-104
Synonyms Atropine | Atropinol | Atropine Sulfate | Sulfate, Atropine | Atropine Sulfate Anhydrous | Anhydrous, Atropine Sulfate | Sulfate Anhydrous, Atropine | AtroPen | Atropin Augen?l | Augen?l, Atropin
Chemical Information
Molecular Formula C17H23NO3
CAS Registry Number 51-55-8
SMILES CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Enuresis19.07.04.001; 20.02.02.003--Not Available
Erythema23.03.06.0010.002060%Not Available
Extensor plantar response17.02.01.005--Not Available
Extrasystoles02.03.02.003--Not Available
Eye pain06.08.03.002--
Fatigue08.01.01.002--
Feeling abnormal08.01.09.014--Not Available
Feeling hot08.01.09.009--Not Available
Flushing08.01.03.025; 23.06.05.003; 24.03.01.0020.001373%
Gastrooesophageal reflux disease07.02.02.003--
Gastrointestinal pain07.01.05.005--
Haemoglobin decreased13.01.05.003--Not Available
Haemoglobin increased13.01.05.004--
Hallucination19.10.02.002--
Hallucination, visual19.10.02.0040.000687%Not Available
Headache17.14.01.0010.001030%
Heart rate increased13.14.04.0020.000687%Not Available
Heterophoria06.05.02.001; 17.02.05.017--Not Available
Hyperglycaemia05.06.02.002; 14.06.02.002--
Hyperhidrosis08.01.03.028; 23.02.03.0040.000687%
Hyperkinesia17.01.02.008--Not Available
Hyperpyrexia08.05.02.002--Not Available
Hyperreflexia17.02.01.002--Not Available
Hypersensitivity10.01.03.003--
Hypertension24.08.02.0010.000687%
Hyperthermia08.05.01.001; 12.05.01.0020.001030%Not Available
Hypertonia15.05.04.007; 17.05.02.0010.000687%Not Available
Hypoglycaemia05.06.03.001; 14.06.03.001--
Hypohidrosis08.01.03.029; 23.02.03.005--
Hypokalaemia14.05.03.002--
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 7 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene